Motor Neurone Disease Trial, Recruiting NCT06566651 Sponsor: University of Aarhus Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06566651
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with ALS:

  • People diagnosed with ALS or probable ALS (based on recognised diagnostic guidelines called the El Escorial Criteria), whether they are able to walk or are in hospital
  • People who are able to give their own informed consent to participate

People with a peripheral neuromuscular disease:

  • People diagnosed with a neuromuscular disease that affects the nerves and muscles but not the brain or spinal cord — examples include Myasthenia Gravis and polyneuropathy — whether they are able to walk or are in hospital
  • People who are able to give their own informed consent to participate

Healthy volunteers:

  • People who are similar in age and gender to the ALS patients in the trial and who are able to give their own informed consent to participate

Who may not be able to join:

All participants:

  • People who have another serious medical, neurological, or psychiatric condition
  • People whose vision is impaired to a degree that would interfere with completing the trial tasks
  • People with severe physical or cognitive difficulties that would prevent them from completing the trial tasks
  • People whose use of alcohol or drugs would interfere with completing the trial tasks

People with a peripheral neuromuscular disease:

  • People who have a family history that increases their risk of developing ALS (confirm with trial site)

Healthy volunteers:

  • People who have a close family member (such as a parent, sibling, or child) with ALS
  • People who take medications that affect the brain or central nervous system, such as antidepressants

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mia B Heintzelmann, Cand.med, Department of Neurology, Aarhus University Hospital

Phone: 78454255

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 December 2023
Est. completion
30 June 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

The perception of facial emotions measured using an Emotion Discrimination Task (EDT).; Metacognitive sensitivity measured using a retrospective confidence rating scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov